14th Oct 2019 12:39
(Alliance News) - Silence Therapeutics PLC on Monday said investor Robert Quested increased his stake in the biotechnology company to 11.33% from 3.76%.
Quested, following a transaction in September, owns 8.9 million shares in Silence Therapeutics.
Silence Therapeutics shares were up 2.1% at 192.00 pence each on Monday afternoon.
By Tapan Panchal; [email protected]
Copyright 2019 Alliance News Limited. All Rights Reserved.
Related Shares:
SLN.L